BTDPF
Barratt Developments PLC$3.91 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $3.91
1 year
−26.2%
from $5.30 · Oct 28
30 days
+0.5%
from $3.89
52-week range
$3.25–5.46
−28% from high · low Mar 20
Avg volume 20D
365
Sep 30 spike 7.0K
Short interest
1.23M
−26.4%
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Oct 15 Short interest falls 26.4% to 1.23M
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −26.4% to 1.23M shares.
- TrendRANGE
2% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Feb 23, 2026 Event
medroxyprogesterone acetate
WARNING: LOSS OF BONE MINERAL DENSITY • Women who use Medroxyprogesterone Acetate (MPA) Injectable S
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Feb 23, 2026
FDA
medroxyprogesterone acetate
WARNING: LOSS OF BONE MINERAL DENSITY • Women who use Medroxyprogesterone Acetate (MPA) Injectable Suspension, USP may lose significant bone mineral d
Feb 19, 2019
Clinical Trial
Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita
Phase 2 · TERMINATED
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 20261,231,646
shares short
-26.4%
vs prior settlement